Fig. 2
Number of adverse events (AEs) belonging to the system organ classes nervous system and psychiatric disorders reported during the titration phase (day 1–14), and following stable dosing (day 15–28)
Fig. 2 | npj Parkinson's Disease
Number of adverse events (AEs) belonging to the system organ classes nervous system and psychiatric disorders reported during the titration phase (day 1–14), and following stable dosing (day 15–28)
